|1.||Djordjevic, Aleksandar: 5 articles (11/2009 - 08/2008)|
|2.||Strukelj, Borut: 4 articles (03/2009 - 08/2008)|
|3.||Cerar, Anton: 4 articles (03/2009 - 08/2008)|
|4.||Injac, Rade: 4 articles (03/2009 - 08/2008)|
|5.||Perse, Martina: 4 articles (03/2009 - 08/2008)|
|6.||Wang, Xinyue: 2 articles (12/2015 - 05/2015)|
|7.||Liu, Yang: 2 articles (12/2015 - 05/2015)|
|8.||Wang, Zuobin: 2 articles (12/2015 - 05/2015)|
|9.||Solajić, Slavica: 2 articles (11/2009 - 05/2008)|
|10.||Bogdanović, Visnja: 2 articles (11/2009 - 05/2008)|
09/22/2009 - "The drug-fullerenol conjugate was found to be relatively stable in phosphate buffer saline but temporally released the active drug when incubated with tumor cell lysate. "
09/22/2009 - "Fullerenol-cytotoxic conjugates for cancer chemotherapy."
05/01/2015 - "In this study, the alterations of the morphology and biomechanical properties of living SMCC-7721 cancer cells treated with fullerenol (C60(OH)24) for 24, 48, and 72h were investigated using an atomic force microscope (AFM). "
09/22/2009 - "Additionally, we demonstrate that the fullerenol platform can be extended to other chemotherapeutic agents, such as the slightly water-soluble cisplatin, and can emerge as a new paradigm in the management of cancer."
09/22/2009 - "Furthermore, in an in vivo murine tumor model, fullerenol-doxorubicin exhibited comparable antitumor efficacy as free drug without the systemic toxicity of free doxorubicin. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
02/01/2009 - "Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer."
02/01/2009 - "The effects of fullerenol C60(OH)24 (Frl) at doses of 25, 50, and 100mg/kg/week (for a time-span of 3 weeks) on heart and liver tissue after doxorubicin (Dox)-induced toxicity in rats with colorectal cancer were investigated. "
|3.||Hepatocellular Carcinoma (Hepatoma)
12/01/2015 - "Quantitative analysis of dynamic adhesion properties in human hepatocellular carcinoma cells with fullerenol."
12/01/2015 - "In this study, the effect of fullerenol (C60(OH)24) on the cellular dynamic biomechanical behaviors of living human hepatocellular carcinoma (SMCC-7721) cancer cells were investigated by atomic force microscope (AFM) nanoindentation. "
08/01/2008 - "The aim of this study was to investigate the potential protective role of fullerenol C60(OH)24 on doxorubicin-induced liver toxicity using in vivo (female Sprague-Dawley rats) and in vitro (human hepatocellular carcinoma - HepG2; colorectal adenocarcinoma cell lines - Caco-2) approaches. "
08/01/1997 - "4. Administration of either fullerenol-1 or deferoxamine, or pre-exposure to chronic hypoxia significantly ameliorated the exsanguination-induced bronchoconstriction. "
08/01/1997 - "1. This study investigated the effects of increased antioxidants (administration of water-soluble fullerenol-1 and pre-exposure to chronic hypoxia) as well as an iron-chelating agent (deferoxamine) on exsanguination-induced noncholinergic airway constriction in guinea-pigs. "
04/01/2000 - "Thirty dogs were divided into three groups (10 in each): The control (C) group received no medication; the preventive (P) group received fullerenol (1 mg/kg) intravenously 30 minutes before ischemia; the therapeutic (T) group received the same dose of fullerenol immediately after reperfusion. "
04/01/2000 - "Free radical scavenging activity of fullerenol on the ischemia-reperfusion intestine in dogs."
04/01/2000 - "The purpose of this study was to investigate whether fullerenol can scavenge the free radicals that are massively induced during ischemia-reperfusion (I/R) injury of the small intestine, either preventively or therapeutically. "
|10.||Lipase (Acid Lipase)
|2.||Drug Therapy (Chemotherapy)